Search for a report

ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2030

ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2030

The Asia-Pacific medical thawing system market is expected to record a CAGR of 8.80% during the forecast period, 2022-2030, and is set to garner a revenue of $84.02 million by 2030.

ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2030

Asia-Pacific Medical Thawing System Market by Sample Type (Blood, Embryo, Ovum, Semen) Market by End-user (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical & Biotech Companies, Other End-users) By Geography

Request free sample

The Asia-Pacific medical thawing system market is expected to record a CAGR of 8.80% during the forecast period, 2022-2030, and is set to garner a revenue of $84.02 million by 2030.

In Asia, lung cancer, chronic obstructive pulmonary diseases (COPDs), diabetes mellitus (DM), and cardiovascular diseases are the leading causes of death. These diseases require timely intervention in the form of blood and plasma donation, which further contributes to the region’s thawing system demands.

Asia Pacific Medical Thawing System Market

To know more about this report, request a free sample copy

In addition, countries like India witness high numbers of road accident deaths. For instance, according to government sources, a total of 449,002 accidents took place in 2019, resulting in 451,361 injuries and 151,113 deaths in the country. The medical thawing system is crucial for blood transfusion logistics, thereby offering growth opportunities.

The Asia-Pacific medical thawing system market growth evaluation includes the assessment of India, South Korea, Japan, China, Singapore, Taiwan, Australia & New Zealand, Indonesia, and Rest of Asia-Pacific. China has high demographics. Also, it has a lucrative economy, enabling investments in medical equipment manufacturing and exports. Additionally, according to government sources, there were 33,000 hospitals in 2019. Besides, as per the country’s National Health Commission (NHC), China witnessed a large number of blood donations recently despite the COVID-19 impact.

Further, according to NHC, with the Blood Donation Law of 1998 in place, blood donations have increased significantly. The law also led to the establishment of 452 blood supply stations and built a multi-layer service network encompassing blood depositories, stations, and supply centers. Such aspects, along with the dense population, blood donations, hospital coverage, manufacturing capabilities, and capital investments, propel China’s market growth.

In South Korea, almost 2.6 million donated blood in 2020. Also, the country’s medical centers, clinics, and hospitals have sperm bank facilities. In addition, the pharma market was valued at $20.9 billion, as per the Korea Health Industry Development Institute in 2020. Since pharma companies are key buyers of thawing systems, the country offers huge scope for the market analyzed. Moreover, the government had established measures at the end of 2020 to tackle declining birth rates. These include encouraging IVF procedures, sperm donation, and embryo freezing. Such factors make South Korea a conducive market for blood thawing systems.

The Asia-Pacific medical thawing system market segmentation includes end-user and sample type. The end-user segment entails pharmaceutical & biotech companies, tissue banks, hospitals, blood banks, and other end-users.

In pharma companies, thawing systems undertake the role of unfreezing the drugs without damaging their chemical properties. Biotech companies thaw biological samples for cell biology research. Whereas pharma companies freeze bulk drug substances during or after production to minimize the biological/chemical degradation, thereby preserving the product’s stability. At the same time, freezing extends product shelf-life and restricts microbial growth. Further, it aids in preventing contamination by reducing the exposure of the drug substance to the walls of the storage container.

Some of the prominent companies in the Asia-Pacific medical thawing system market include Terumo Corporation, Sartorius AG, Single Use Support GmbH, Thermo Fisher Scientific Inc, etc.

Terumo Corporation develops, manufactures, and distributes medical devices and services globally. The company’s blood and cell technologies segment offers centrifugal apheresis systems, pathogen reduction technology, automated blood processing systems, etc. It operates in North America, Asia, the Middle East & Africa, and Latin America, with headquarters in Tokyo, Japan.

One of its key products includes a plasma bath (PB 100) that offers the optimum thawing mechanism for plasma with a capacity of up to 12p plasma bags in a single thawing cycle.

Report Synopsis:

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Sample Type, End-User
Countries Analyzed India, South Korea, Japan, China, Singapore, Taiwan, Australia & New Zealand, and Rest of Asia-Pacific
Companies Analyzed

Barkey GmbhH & Co Kg, BioLife Solutions Inc, Boekel Scientific, Cardinal Health, Caron Products & Services Inc, Danaher Corporation, FreMon Scientific, Helmer Scientific, KW Apparecchi Scientifici, Meissner, Sarstedt AG & Co KG, Sartorius AG, Single Use Support GmbhH, Terumo Corporation, Thermo Fisher Scientific Inc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • HIGH PREVALENCE OF CHRONIC DISEASES
        • GROWING NEED FOR BLOOD TRANSFUSION DUE TO VEHICULAR ACCIDENTS
        • INCREASING EMBRYO FREEZING AMONG WOMEN
      • KEY RESTRAINTS
        • LACK OF SKILLED LABOR
        • SOCIETAL RESTRAINTS REGARDING ASSISTED REPRODUCTIVE TECHNOLOGY
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON MEDICAL THAWING SYSTEM MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY SAMPLE TYPE
      • BLOOD
      • EMBRYO
      • OVUM
      • SEMEN
    3. MARKET BY END-USER
      • BLOOD BANKS
      • HOSPITALS
      • TISSUE BANKS
      • PHARMACEUTICAL & BIOTECH COMPANIES
      • OTHER END-USERS
    4. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • TAIWAN
          • SINGAPORE
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
        • DIVESTITURES
      • COMPANY PROFILES
        • BARKEY GMBH & CO KG
        • BIOLIFE SOLUTIONS INC
        • BOEKEL SCIENTIFIC
        • CARDINAL HEALTH
        • CARON PRODUCTS & SERVICES INC
        • DANAHER CORPORATION
        • FREMON SCIENTIFIC
        • HELMER SCIENTIFIC
        • KW APPARECCHI SCIENTIFICI
        • MEISSNER
        • SARSTEDT AG & CO KG
        • SARTORIUS AG
        • SINGLE USE SUPPORT GMBH
        • TERUMO CORPORATION
        • THERMO FISHER SCIENTIFIC INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – MEDICAL THAWING SYSTEM

    TABLE 2: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 8: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET

    TABLE 9: LIST OF MERGERS & ACQUISITIONS

    TABLE 10: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 11: LIST OF DIVESTITURES                        

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, GROWTH POTENTIAL, BY SAMPLE TYPE, IN 2021

    FIGURE 6: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY BLOOD, 2022-2030 (IN $ MILLION)

    FIGURE 7: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY EMBRYO, 2022-2030 (IN $ MILLION)

    FIGURE 8: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY OVUM, 2022-2030 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SEMEN, 2022-2030 (IN $ MILLION)

    FIGURE 10: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

    FIGURE 11: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY BLOOD BANKS, 2022-2030 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY TISSUE BANKS, 2022-2030 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY PHARMACEUTICAL & BIOTECH COMPANIES, 2022-2030 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 17: CHINA MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 18: JAPAN MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 19: INDIA MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 20: SOUTH KOREA MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 21: INDONESIA MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 22: TAIWAN MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 23: SINGAPORE MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 24: AUSTRALIA & NEW ZEALAND MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 25: REST OF ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • TAIWAN
          • SINGAPORE
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. MARKET BY SAMPLE TYPE
      • BLOOD
      • EMBRYO
      • OVUM
      • SEMEN
    2. MARKET BY END-USER
      • BLOOD BANKS
      • HOSPITALS
      • TISSUE BANKS
      • PHARMACEUTICAL & BIOTECH COMPANIES
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now